{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:46:12Z","timestamp":1760121972018},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:00:00Z","timestamp":1299542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11897-011-0052-x","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:10:09Z","timestamp":1299543009000},"page":"99-105","source":"Crossref","is-referenced-by-count":20,"title":["Renal Biomarkers of Kidney Injury in Cardiorenal Syndrome"],"prefix":"10.1007","volume":"8","author":[{"given":"Mark","family":"Comnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areef","family":"Ishani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,8]]},"reference":[{"key":"52_CR1","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/CIRCULATIONAHA.109.192667","volume":"121","author":"VL Roger","year":"2010","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics\u20142010 update: a report from the American Heart Association. Circulation. 2010;121:e46\u2013214.","journal-title":"Circulation"},{"key":"52_CR2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","volume":"31","author":"C Ronco","year":"2010","unstructured":"\u2022 Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010;31:703\u201311. This is a detailed description of the five types of cardiorenal syndromes.","journal-title":"Eur Heart J"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2215\/CJN.03150509","volume":"4","author":"M Sarraf","year":"2009","unstructured":"\u2022\u2022 Sarraf M, Masoumi A, Schrier R. Cardiorenal syndrome in acute decompensated heart failure. CJASN 2009;4:2013\u201326. This is a thorough, in-depth review of the proposed pathophysiology involved in cardiorenal syndromes.","journal-title":"CJASN"},{"key":"52_CR4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","volume":"3","author":"P Stenvinkel","year":"2008","unstructured":"\u2022\u2022 Stenvinkel P, Carrero JJ, Axelson J, et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? CJASN 2008, 3: 505\u201321. This is an excellent discussion of systemic effects in chronic kidney disease and their contribution to morbidity and mortality.","journal-title":"CJASN"},{"key":"52_CR5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","volume":"8","author":"SS Gottlieb","year":"2002","unstructured":"Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Failure. 2002;8:136\u201341.","journal-title":"J Card Failure"},{"key":"52_CR6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","volume":"53","author":"K Damman","year":"2009","unstructured":"Damman K, Deursen VM, Navis G, et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53:582\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR7","doi-asserted-by":"crossref","unstructured":"Damman K, Voors AA, Hillege HL, et al. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J of Heart Fail 2010;1\u20139.","DOI":"10.1093\/eurjhf\/hfq118"},{"key":"52_CR8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","volume":"51","author":"A Nohria","year":"2008","unstructured":"Nohria A, Hasselblad V, Stebbens A, et al. Cardiorenal interactions insights from the ESCAPE trial. J Am Coll Cardiol. 2008;51:1268\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589\u201396.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-8703(99)70009-8","volume":"138","author":"EL Knight","year":"1999","unstructured":"Knight EL, Glynn RJ, McIntyre KM, et al. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD). Am Heart J. 1999;138:849\u201355.","journal-title":"Am Heart J"},{"key":"52_CR11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehi859","volume":"27","author":"MR Cowie","year":"2006","unstructured":"Cowie MR, Komajda M, Murray-Thomas T, et al. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006;27:1216\u201322.","journal-title":"Eur Heart J"},{"key":"52_CR12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","volume":"9","author":"K Damman","year":"2007","unstructured":"Damman K, Navis G, Smilde TDJ, et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J of Heart Fail. 2007;9:872\u20138.","journal-title":"Eur J of Heart Fail"},{"key":"52_CR13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/eurjhf\/hfp184","volume":"12","author":"AV Perez","year":"2010","unstructured":"Perez AV, Otawa K, Zimmermann AV, et al. The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure. Eur J of Heart Failure. 2010;12:122\u20138.","journal-title":"Eur J of Heart Failure"},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","volume":"51","author":"W Mullens","year":"2008","unstructured":"Mullens W, Abrahams Z, Skouri HN, et al. Elevated intra-abdominal pressure in acute decompensated heart failure. J Am Coll Cardiol. 2008;51:300\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cardfail.2008.02.010","volume":"14","author":"W Mullens","year":"2008","unstructured":"Mullens W, Abrahams Z, Francis GS, et al. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J of Card Fail. 2008;14:508\u201314.","journal-title":"J of Card Fail"},{"key":"52_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cardfail.2009.12.009","volume":"16","author":"MR Constanza","year":"2010","unstructured":"Constanza MR, Saltzberg MT, Jessup M, et al. Ultrafiltration is associated with fewer hospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J of Card Fail. 2010;16:277\u201384.","journal-title":"J of Card Fail"},{"key":"52_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","volume":"43","author":"DE Forman","year":"2004","unstructured":"Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. JACC. 2004;43:61\u20137.","journal-title":"JACC"},{"key":"52_CR18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejheart.2008.01.011","volume":"10","author":"M Metra","year":"2008","unstructured":"Metra M, Nodari S, Parrinello G, et al. Worsening renal function in patients hospitalized for acute heart failure: clinical implications and prognostic significance. Eur J of Heart Fail. 2008;10:188\u201395.","journal-title":"Eur J of Heart Fail"},{"key":"52_CR19","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","volume":"47","author":"GL Smith","year":"2006","unstructured":"Smith GL, Lichtman JH, Bracken MB, et al. Renal Impairment and outcomes in heart failure. J Am Coll Cardiol. 2006;47:1987\u201396.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurjhf\/hfp108","volume":"11","author":"K Damman","year":"2009","unstructured":"Damman K, Jaarsma T, Voors AA, et al. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J of Heart Fail. 2009;11:847\u201354.","journal-title":"Eur J of Heart Fail"},{"key":"52_CR21","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1751-7133.2010.00163.x","volume":"16","author":"DM Cruz","year":"2010","unstructured":"Cruz DM, Goh CY, Haase-Fielitz A, et al. Early biomarkers of renal injury. Congest Heart Fail. 2010;16:S25\u201331.","journal-title":"Congest Heart Fail"},{"key":"52_CR22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00059-009-3316-4","volume":"34","author":"M Lainscak","year":"2009","unstructured":"Lainscak M, Anker MS, Haehling S, et al. Biomarkers for chronic heart failure. Herz. 2009;34:589\u201393.","journal-title":"Herz"},{"key":"52_CR23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2796.2001.00833.x","volume":"249","author":"HL Hillege","year":"2001","unstructured":"Hillege HL, Janssen WMT, Bak AAA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249:519\u201326.","journal-title":"J Intern Med"},{"key":"52_CR24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/01.hjh.0000226206.03560.ac","volume":"24","author":"F Bonnet","year":"2006","unstructured":"Bonnet F, Marre M, Halimi JM, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J of Hypertension. 2006;24:1157\u201363.","journal-title":"J of Hypertension"},{"key":"52_CR25","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","volume":"106","author":"HL Hillege","year":"2002","unstructured":"Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777\u201382.","journal-title":"Circulation"},{"key":"52_CR26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000133312.96477.48","volume":"110","author":"K Klausen","year":"2004","unstructured":"Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110:32\u20135.","journal-title":"Circulation"},{"key":"52_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein HC, Mann JFE, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421\u20136.","journal-title":"JAMA"},{"key":"52_CR28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/ki.2010.8","volume":"77","author":"T Reffelmann","year":"2010","unstructured":"Reffelmann T, Dorr M, Volzke H, et al. Urinary albumin excretion, even within the normal range, predicts an increase in left ventricular mass over the follow 5\u00a0years. Kidney Int. 2010;77:1115\u201322.","journal-title":"Kidney Int"},{"key":"52_CR29","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/eurheartj\/ehm130","volume":"28","author":"E Ingelsson","year":"2007","unstructured":"Ingelsson E, Sundstrom J, Lind L, et al. Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J. 2007;28:1739\u201345.","journal-title":"Eur Heart J"},{"key":"52_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","volume":"374","author":"CE Jackson","year":"2009","unstructured":"\u2022 Jackson CE, Soloman SD, Gerstein HC, et al. Albuminura in chronic heart failure: prevalence and prognostic importance. Lancet 2009;374:543\u201350. This is an interesting analysis of the morbidity and mortality of albuminuria from the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) trial.","journal-title":"Lancet"},{"key":"52_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.109.881805","volume":"3","author":"S Masson","year":"2010","unstructured":"\u2022 Masson S, Latini VM, Moretti L, et al. Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure. Circulation Heart Failure 2010;3:65\u201372. This is a second interesting analysis of the morbidity and mortality of albuminuria from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico [Italian group for the study of the survival of myocardial infarction]) trial.","journal-title":"Circulation Heart Failure"},{"key":"52_CR32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.109.853648","volume":"120","author":"IS Anand","year":"2009","unstructured":"Anand IS, Bishu K, Rector TS, et al. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Circulation. 2009;120:1577\u201384.","journal-title":"Circulation"},{"key":"52_CR33","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/ndt\/gfp310","volume":"24","author":"D Bolignano","year":"2009","unstructured":"Bolignano D, Coppolino G, Romeo A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients. Nephrol Dial Transplant. 2009;24:3398\u2013403.","journal-title":"Nephrol Dial Transplant"},{"key":"52_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000315436","volume":"33","author":"J Malysko","year":"2010","unstructured":"Malysko J, Tesar V, Macdougall IC. Neutrophil gelatinase-associated lipocalin and hepcidin: what do they have in common and is there a potential interaction? Kidney Blood Press Res. 2010;33:157\u201365.","journal-title":"Kidney Blood Press Res"},{"key":"52_CR35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1003708808934","volume":"31","author":"A Friedl","year":"1999","unstructured":"Friedl A, Stoesz SP, Buckley P, et al. Neutrophil gelatinase associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J. 1999;31:433\u201341.","journal-title":"Histochem J"},{"key":"52_CR36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2010.06.023","volume":"56","author":"E Meijer","year":"2010","unstructured":"Meijer E, Boertien WE, Nauta FL, et al. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Am J Kid Dis. 2010;56:883\u201395.","journal-title":"Am J Kid Dis"},{"key":"52_CR37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clim.2007.01.010","volume":"123","author":"H Ding","year":"2007","unstructured":"Ding H, He Y, Li K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007;123:227\u201334.","journal-title":"Clin Immunol"},{"key":"52_CR38","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1681\/ASN.2009010065","volume":"20","author":"N Paragas","year":"2009","unstructured":"Paragas N, Nickolas TL, Wyatt C, et al. Urinary NGAL marks cystic disease in HIV-associated nephropathy. JASN. 2009;20:1687\u201392.","journal-title":"JASN"},{"key":"52_CR39","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00467-009-1279-6","volume":"24","author":"A Yilmaz","year":"2009","unstructured":"Yilmaz A, Sevketoglu E, Gedikbasi A, et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol. 2009;24:2387\u201392.","journal-title":"Pediatr Nephrol"},{"key":"52_CR40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00134-009-1724-9","volume":"36","author":"SM Bagshaw","year":"2010","unstructured":"Bagshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010;36:452\u201361.","journal-title":"Intensive Care Med"},{"key":"52_CR41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2215\/CJN.04010907","volume":"3","author":"M Bennett","year":"2008","unstructured":"Bennett M, Dent CL, Ma Q, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. CJASN. 2008;3:665\u201374.","journal-title":"CJASN"},{"key":"52_CR42","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","volume":"365","author":"J Mishra","year":"2005","unstructured":"Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231\u20138.","journal-title":"Lancet"},{"key":"52_CR43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FJC.0b013e31819d6139","volume":"53","author":"SM Tuladhar","year":"2009","unstructured":"Tuladhar SM, Puntmann VO, Soni M, et al. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol. 2009;53:261\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"key":"52_CR44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2215\/CJN.04810908","volume":"4","author":"W Han","year":"2009","unstructured":"Han W, Wagener G, Zhu Y, et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. CJASN. 2009;4:873\u201382.","journal-title":"CJASN"},{"key":"52_CR45","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/08860220802359089","volume":"30","author":"C Xin","year":"2008","unstructured":"Xin C, Yulong X, Yu C, et al. Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Ren Fail. 2008;30:904\u201313.","journal-title":"Ren Fail"},{"key":"52_CR46","doi-asserted-by":"crossref","unstructured":"Heise D, Rentsch K, Braeuer A, et al. Comparison of urinary neutrophil glucosaminidase-associated lipocalin, cystatin-C, and \u03b11-microglobulin for early detection of acute renal injury after cardiac surgery. European J of Cardio-Thoracic Surgery 2010; in press.","DOI":"10.1016\/j.ejcts.2010.05.044"},{"key":"52_CR47","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ejheart.2008.07.001","volume":"10","author":"K Damman","year":"2008","unstructured":"Damman K, Veldhuisen DJ, Navis G, et al. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. European J of Heart Failure. 2008;10:997\u20131000.","journal-title":"European J of Heart Failure"},{"key":"52_CR48","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/hrt.2010.194878","volume":"96","author":"K Damman","year":"2010","unstructured":"Damman K, Veldhuisen DJ, Navis G, et al. Tubular damage is chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart. 2010;96:1297\u2013302.","journal-title":"Heart"},{"key":"52_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cardfail.2009.07.003","volume":"16","author":"A Aghel","year":"2010","unstructured":"Aghel A, Shrestha K, Mullens W, et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J of Cardiac Failure. 2010;16:49\u201354.","journal-title":"J of Cardiac Failure"},{"key":"52_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCC.0b013e32833500bc","volume":"16","author":"JV Bonventre","year":"2010","unstructured":"Bonventre JV, Yang L. Kidney injury molecule-1. Curr Opin Crit Care. 2010;16:1\u20136.","journal-title":"Curr Opin Crit Care"},{"key":"52_CR51","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1681\/ASN.2004070530","volume":"16","author":"WK Han","year":"2005","unstructured":"Han WK, Alinani A, Wu CL, et al. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. JASN. 2005;16:1126\u201334.","journal-title":"JASN"},{"key":"52_CR52","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1681\/ASN.2006030221","volume":"18","author":"O Liangos","year":"2007","unstructured":"Liangos O, Perianayagam MC, Vaidya VS, et al. Urinary N-acetyl-\u03b2-(D)-glucosaminidase activity and kidney injury molecule-1 are associated with adverse outcomes in acute renal failure. JASN. 2007;18:904\u201312.","journal-title":"JASN"},{"key":"52_CR53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.ajkd.2003.10.040","volume":"43","author":"CR Parikh","year":"2004","unstructured":"Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004;43:405\u201311.","journal-title":"Am J Kidney Dis"},{"key":"52_CR54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.ki.5001527","volume":"70","author":"CR Parikh","year":"2006","unstructured":"Parikh CR, Mishra J, Theissen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70:199\u2013203.","journal-title":"Kidney Int"},{"key":"52_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6972","volume":"12","author":"M Haase","year":"2008","unstructured":"Haase M, Bellomo R, Story D, et al. Urinary interleukin-18 does not predict acute kidney injury after adult cardiac surgery: a prospective observational cohort study. Crit Care. 2008;12:1\u20138.","journal-title":"Crit Care"},{"key":"52_CR56","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1681\/ASN.2005030236","volume":"16","author":"CR Parikh","year":"2005","unstructured":"Parikh CR, Abraham E, Ancukiewicz M, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. JASN. 2005;16:3046\u201352.","journal-title":"JASN"},{"key":"52_CR57","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.2003.00925.x","volume":"63","author":"M Fricker","year":"2003","unstructured":"Fricker M, Wiesli P, Brandle M, et al. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003;63:1944\u20137.","journal-title":"Kidney Int"},{"key":"52_CR58","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/ki.2008.341","volume":"74","author":"JL Koyner","year":"2008","unstructured":"Koyner JL, Bennett MR, Worcester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74:1059\u201369.","journal-title":"Kidney Int"},{"key":"52_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc9014","volume":"14","author":"M Nejat","year":"2010","unstructured":"Nejat M, Pickering JW, Walker RJ, et al. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care. 2010;14:1\u20131.","journal-title":"Crit Care"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-011-0052-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-011-0052-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-011-0052-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T00:16:59Z","timestamp":1560039419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-011-0052-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,8]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s11897-011-0052-x","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,8]]}}}